GenomOncology has appointed Benjamin Salisbury as vice president of new products and marketing. He will be responsible for the company's corporate marketing and for bringing to market new products that build upon the company's precision medicine technology. Salisbury joins the company from Knome, where he guided the transition of the company's research-focused, internal-use software for next-generation sequencing analysis to a product that supports clinical laboratory operations. He has also held several management and scientific positions at Transgenomic, PGxHealth, and Genaissance Pharamaceuticals. As a scientist, Salisbury's expertise includes molecular diagnostics, pharmacogenomics, population genetics, statistical genetics, and algorithm development. He has authored over 30 peer-reviewed publications in these and other fields.